Kotaro Sakamoto
Motosu, 5010475, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
An Improved Brain-Penetrating Nanoformulation of the VIPR2 Antagonist Peptide KS-133 for Treating Cognitive Impairment in Schizophrenia.
Journal: Biological & pharmaceutical bulletin
Published: June 28, 2026
Epigenetic regulation of hyaluronan degradation and melanogenesis by Kawarayomogin I and II from Artemisia capillaris via miR-486-5p and miR-141-3p.
Journal: Molecular biology reports
Published: January 09, 2026
A Next-Generation Brain-Targeting Peptide: KS-487 Rivals Angiopep-2 in BBB Penetration with Enhanced Selectivity.
Journal: Bioconjugate chemistry
Published: September 11, 2025
A novel drug target VIPR2 to regulate migration and proliferation in breast cancer
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Published: April 30, 2025
Artemisia capillaris with two novel active compounds, Kawarayomogin I and II, inhibits HYBID (KIAA1199) expression as well as hyaluronic acid degradation.
Journal: Scientific reports
Published: August 30, 2024
Anthricin-induced hyperactive proteasome and its molecular mechanism.
Journal: Biochemistry and biophysics reports
Published: August 16, 2024
Information structure of heterogeneous criticality in a fish school.
Journal: Scientific reports
Published: May 29, 2024
Mentha piperita leaf extract suppresses the release of ATP from epidermal keratinocytes and reduces dermal thinning as well as wrinkle formation.
Journal: International journal of cosmetic science
Published: December 18, 2023
Lipid bilayer membrane permeability mechanism of the K-Ras(G12D)-inhibitory bicyclic peptide KS-58 elucidated by molecular dynamics simulations.
Journal: Bioorganic & medicinal chemistry letters
Published: December 15, 2023
Development of a simultaneous LC-MS/MS analytical method for plasma: 16 antipsychotics approved in Japan and 4 drug metabolites.
Journal: Analytical sciences : the international journal of the Japan Society for Analytical Chemistry
Published: December 03, 2023
Blockade of vasoactive intestinal peptide receptor 2 (VIPR2) signaling suppresses cyclin D1-dependent cell-cycle progression in MCF-7 cells.
Journal: Journal of pharmacological sciences
Published: November 01, 2023
Last Updated: 09/26/2026